Praxis Precision Medicines (PRAX) Payables (2019 - 2026)

Praxis Precision Medicines' Payables history runs 8 years deep, the most recent figure standing at $31.2 million for Q1 2026.

• In Q1 2026, Payables rose 36.01% year-over-year to $31.2 million; the TTM figure through Mar 2026 stood at $31.2 million (up 36.01% YoY), while the FY2025 annual figure was $24.6 million, up 96.58% from the prior year.
• Payables was $31.2 million for Q1 2026 at Praxis Precision Medicines, up from $24.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $31.2 million in Q1 2026 to a low of $5.8 million in Q4 2023.
• Historically, Payables has averaged $16.0 million across 5 years, with a median of $13.3 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Payables plunged 60.37% in 2023, then surged 251.82% in 2025.
• A 5-year view of Payables shows it stood at $14.7 million in 2022, then slumped by 60.37% to $5.8 million in 2023, then soared by 115.44% to $12.5 million in 2024, then surged by 96.58% to $24.6 million in 2025, then increased by 26.51% to $31.2 million in 2026.
• The last three Payables figures came in at $31.2 million (Q1 2026), $24.6 million (Q4 2025), and $30.8 million (Q3 2025), per Business Quant data.